Literature DB >> 30207812

Functional strength measurement in cerebral palsy: feasibility, test-retest reliability, and construct validity.

Wendy Aertssen1, Ellen Smulders1, Bouwien Smits-Engelsman2, Eugene Rameckers1.   

Abstract

Purpose: No instrument exists that measures functional strength in both lower and upper extremities in children with cerebral palsy (CP). Therefore, the functional strength measurement (FSM) was tested for feasibility, test-retest reliability and validity in CP.
Methods:  Thirty-seven children with CP (aged 4-10 years, Gross Motor Function Classification System I and II) participated. The most common compensations for CP were described; new item descriptions were standardized, and one item was removed. Test-retest reliability was examined. To measure convergent validity, correlations between the FSM-CP and isometric muscle strength measured with the handheld dynamometer (HHD) were determined.
Results:  Test-retest reliability was considered high for all items (intra-class correlation coefficient 0.79-0.95). Significant correlations between the HHD and FSM-CP ranged from r = 0.36 to 0.75.
Conclusion:  The FSM-CP is feasible, reliable, and valid to use in children with CP. The FSM-CP can be considered as a helpful tool in clinical practice of physical examination of children with CP.

Entities:  

Keywords:  Cerebral palsy; children; feasibility; functional strength measurement; reliability; validity

Mesh:

Year:  2018        PMID: 30207812     DOI: 10.1080/17518423.2018.1518963

Source DB:  PubMed          Journal:  Dev Neurorehabil        ISSN: 1751-8423            Impact factor:   2.308


  1 in total

1.  Progressive resistance training for children with cerebral palsy: A randomized controlled trial evaluating the effects on muscle strength and morphology.

Authors:  Britta Hanssen; Nicky Peeters; Nathalie De Beukelaer; Astrid Vannerom; Leen Peeters; Guy Molenaers; Anja Van Campenhout; Ellen Deschepper; Christine Van den Broeck; Kaat Desloovere
Journal:  Front Physiol       Date:  2022-10-04       Impact factor: 4.755

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.